Skip to main content
Log in

Lebererkrankungen

Werden microRNA unsere NAFLD-Marker sein?

  • journal club
  • Published:
Gastro-News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Younossi ZM et al. Hepatology 2016;64(1):73–84

    Article  Google Scholar 

  2. Loosen SH et al. World J Hepatol 2017;9(12):586–94

    Article  Google Scholar 

  3. Dongiovanni P et al. Int J Mol Sci 2018; 19(12). pii: E3966

  4. Gottlieb A et al. Digestion 2018:1–7

    Google Scholar 

  5. Pritchard CC et al. Nat Rev Genet 2012;13(5): 358–69

    Article  CAS  Google Scholar 

Literatur

  • Liu CH et al. miRNA in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. J of Hepatology December 2018;69:6:1335–48

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ali Canbay.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gottlieb, A., Canbay, A. Werden microRNA unsere NAFLD-Marker sein?. Gastro-News 6, 20–21 (2019). https://doi.org/10.1007/s15036-019-0561-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15036-019-0561-0

Navigation